North Haven, CTNCT06292923Now EnrollingIRB Ready

Multiple Sclerosis Clinical Trial in North Haven, CT

Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in North Haven. Study-provided care at no cost to qualified participants.

Sponsored by Tiziana Life Sciences LTD

Quick Self-Assessment

See if you qualify for this North Haven location

Preparing your pre-screening questions...

Expert Care in North Haven

Access multiple sclerosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple sclerosis treatment provided free

Apply for This North Haven Location

Check if you qualify for this multiple sclerosis clinical trial in North Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to North Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit North Haven site if eligible
  4. 4Begin participation

About This Multiple Sclerosis Study in North Haven

Foralumab is a human anti-CD3 monoclonal antibody being developed for the treatment of autoimmune and inflammatory diseases. The goal of this Phase 2a, randomized, double-blind placebo-controlled, multicenter dose-ranging study is to evaluate the use of nasal foralumab in patients with non-active secondary progressive multiple sclerosis (SPMS). The primary objectives that this study aims to answer are: 1. To determine the safety and tolerability of 50 μg/dose and 100 μg/dose of foralumab nasa

Sponsor: Tiziana Life Sciences LTD

Who Can Participate

Inclusion Criteria

Confirmed diagnosis of MS according to the 2017 McDonald criteria . 2. Age 18 years to age 75 years. 3. Confirmed clinical diagnosis of non-active SPMS, for 2 years prior to the screening visit. The baseline study visit and/or the baseline MRI may not be used to confirm the diagnosis but will be used to establish a study baseline and for interpretation of the PET scan data. The second qualifying MRI must be within 3 months of the study screening MRI. 4. MRI imaging consistent with a diagnosis of MS at any time point. 5. Score on the Expanded Disability Status Scale (EDSS) of 2.5-6.5. 6. Have failed standard-of-care treatment with disease-modifying therapies for at least 2 years with continued accumulation of disability as evaluated by treating neurologist. Treatment failure/progression can be defined as EDSS worsening despite best treatment efforts:
EDSS increase by 1.0 (if baseline EDSS between 1.0-5.5) in the past 2 years.
EDSS increase by 0.5 (if baseline EDSS \>6.0) i

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in North Haven?

Yes, this clinical trial (NCT06292923) has an active research site in North Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Sclerosis Treatment Options in North Haven, CT

If you're searching for multiple sclerosis treatment options in North Haven, CT, this clinical trial (NCT06292923) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our North Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple sclerosis clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in North Haven, CT

See all multiple sclerosis clinical trials recruiting in North Haven — not just this study.

Browse Multiple Sclerosis Trials in North Haven →

Browse More Trials by Condition

Multiple Sclerosis TrialsAll Conditions →

Ready to Join in North Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · North Haven, CT